Comprehensive Clinical Management: Focus On Patients With Spasticity Due To Stroke, Traumatic Brain Injury (TBI), Spinal Cord Injury (SCI), and Other Etiologies
Live, In-Person Workshop
Date: Saturday, December 11, 2021
Time: 10:15 AM-4:00 PM
Location: Houston Marriott Medical Center, 6580 Fannin Street, Houston, Texas 77030
(Driveway entrance is on 1730 Dryden Road)
- University of Utah School of Medicine: 5.75 CME credits
- Texas Board of Physical Therapy Examiners: 5.25 CCUs
- American Occupational Therapy Association (AOTA): 0.5 CEU (5 contact hours)
- American Speech-Language-Hearing Association (ASHA): 0.45 CEU
This workshop provides an integrated and comprehensive interdisciplinary approach to effective spasticity management using a combination of neurotoxin therapy and appropriate adjunctive care encompassing physical therapy (PT), occupational therapy (OT), and/or speech-language pathology (SLP).
The program offers a unique demonstration of how all aspects of patient care—from pre-injection screening and clinical assessment to post-injection follow up—fit into a total treatment plan for post-stroke, TBI, SCI, and other spasticity patients (including those with multiple sclerosis [MS] and cerebral palsy [CP]).
Approximately 17-43% of post-stroke, 34-84% TBI, 31-78% SCI, 40-80% MS, and 72-91% of CP patients experience spasticity.
The workshop features:
- Interactive video grand rounds with longitudinal follow up of select cases managed using a comprehensive treatment approach
- Live patient case presentations involving the interdisciplinary team’s “real time” assessment, treatment (ie, neurotoxin injections), recommendations for adjunctive rehabilitation therapies, and home exercise programs
- Hands-on physicians’ workshop focused on ultrasound guidance
- Therapists’ workshop centered on effective treatment team communication and application of targeted home exercise/rehabilitation programs.
- Recognize the importance, benefits, challenges, and practical concerns regarding the interdisciplinary team approach for management of patients with spasticity, in order to develop individualized treatment plans
- Interpret the clinical evidence, guidelines, and recommendations on the use of neurotoxins and adjunctive rehabilitation interventions (PT/OT/SLP), both alone and in combination, in order to establish appropriate treatment strategies for these patients
- Assess neuromuscular pathology and individual patient functional goals, in order to identify appropriate muscles, determine dosing, maximize therapeutic benefit, and minimize complications
- Evaluate methods of guidance and localization (ie, EMG, E-stim, ultrasound), in order to incorporate best practices for proper placement of neurotoxin
- Facilitate interaction and improve communication among members of the interdisciplinary treatment team, in order to encourage appropriate referrals for both neurotoxin injection and adjunctive therapy that may optimize patient outcomes
- Apply optimal guidance and localization techniques, especially ultrasound technology, in order to improve efficacy in injecting BoNT for treatment of spasticity
- Integrate home exercise programs into spasticity management post-BoNT, in order to optimize patient rehabilitation outcomes
It is recommended that you view the On Demand CCM Workshop prior to attending this live, in-person event. The on-line presentation of the virtual workshop, which was streamed on May 1, 2021 featured didactic presentations with Q & A sessions as well as video grand rounds featuring patients with spasticity, and an interactive expert panel discussion. This On Demand workshop is 4-1/2 hours long and is accredited by the University of Utah School of Medicine for 5.25 CME credits and AOTA for 0.4 CEU. Individuals who obtained CME/CE credits for participation in the virtual CCM workshop that was held on May 11, 2021, may not claim CME/CE credits for viewing the On Demand Workshop.
Click here to view the On Demand CCM workshop
|10:15 AM – 10:30 AM||Welcome and Program Objectives
Cindy Ivanhoe, MD
|10:30 AM – 10:45 AM||The Team Approach to Effective Patient Management
Katharine Alter, MD
|10:45 AM –11:45 AM||Interactive Video Grand Rounds: Longitudinal Follow-up
The Treatment Team
|11:45 AM – 12:30 PM||Lunch|
|12:30 PM – 2:00 PM||
Physicians’ Workshop – A Hands-on Session:
Therapists’ Workshop – Facilitating Therapist and Physician Communication: Bringing It All Together to Optimize Patient Outcomes
|2:00 PM – 2:15 PM||Break|
|2:15 PM – 3:45 PM||Patient Workshop
Live patient assessments, injections, and recommendations for home exercise programs
The Treatment Team
|3:45 PM – 4:00 PM||Closing Remarks
Cindy Ivanhoe, MD
Click here for speaker disclosure information.
Physiatrists, neurologists, physical therapists, occupational therapists, speech-language pathologists, and other healthcare professionals who manage patients with spasticity.
This workshop is intended for healthcare professionals only.
Financial Support Disclosure: Allergan, an AbbVie company, provided an independent educational grant for this course.
In-Kind Support Disclosure: Allergan also provided disposable and biological supplies for this course.
Registration payment: $69.00 (Lunch included)
Tuition fee for Residents and Fellows who provide a copy of their work credential to qualify: $29.00 (Lunch included)
Tuition fees on cancellations by registrants are refundable until November 24, 2021. In the event the workshop is cancelled, registration fees will be reimbursed.
Accreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Speaker and Planning Committee Disclosure Summary:
The University of Utah School of Medicine Continuing Medical Education Office (UUCME) meets ACCME Standards for Integrity and Independence expectations regarding the identification and mitigation of relevant financial relationships with ACCME-defined ineligible companies. Everyone in control of content, including all speakers and planners, must disclose financial relationships in any amount within the past 24 months and any relevant financial relationships must be mitigated prior to the activity start.
Disclosure: Neither planners, speakers, or anyone in control of content have any relevant financial relationships with an ACCME-defined ineligible company to disclose or mitigate.
AMA Credit: The University of Utah School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All attendees are encouraged to use the CME system to claim their attendance. Physicians will be awarded AMA PRA Category 1 credits™; all other professions will be awarded attendance at a CME event credit that they may use for their re-credentialing purposes. Nurses seeking contact hours must claim through the CME system. All users will be able to print or save certificates. For questions regarding the CME system, please contact the UUCME Office. For questions regarding re-credentialing process or requirements, please contact your re-credentialing organization.
Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).
AOTA Credit for Occupational Therapists
Scientiae, LLC, is an AOTA-Approved Provider of accredited OT CEU, approved in the areas of Live Activities, Distance Learning – Interactive, and Distance Learning – Independent. Our AOTA Approved Provider Number is 6346. Course approval ID# 1947.
This activity is appropriate for OT participants at all levels: introductory, intermediate, and advanced.
This Live, In-Person Workshop is offered at 0.5 CEU. Participants requiring AOTA CEUs will be required to complete a post-test on completion of the meeting exit evaluation/survey. In order to meet completion requirements for this activity and earn CEUs, participants must score at least 70% by answering a minimum of 7 of 10 questions correctly on the post-test. Participants may take the post-test multiple times until the required score is achieved. The post-test must be successfully completed by end of business on January 11, 2022.
Credit for Physical Therapists (PTs) and Physical Therapist Assistants (PTAs)
This activity has been approved by the Texas Board of Physical Therapy Examiners for 5.25 CCUs for PTs and PTAs. PT and PTA participants requiring CCUs are required to complete a post-test on completion of the meeting exit evaluation/survey. To meet completion requirements for this workshop and earn CCUs, participants must score at least 70% by answering a minimum of 7 of 10 questions correctly on the post-test. Participants may take the post-test multiple times until the required score is achieved. The post-test must be successfully completed by end of business on January 11, 2022.
ASHA Credit for Speech-Language Pathologists
This course is offered at 0.45 American Speech-Language-Hearing Association (ASHA) CEU. Participants requiring ASHA CEUs are required to complete a post-test on completion of the meeting exit evaluation/survey. To meet completion requirements for this activity and earn CEUs, Speech-Language Pathology participants must score at least 70% by answering a minimum of 7 of 10 questions correctly on the post-test. Participants may take the post-test multiple times until the required score is achieved. The post-test must be successfully completed by end of business on January 11, 2022.
Carol Tucker, MSc
Senior Vice President, Scientific Affairs
New York, New York